[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"critical-illness-myopathy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:critical-illness-myopathy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,48,80,110,140,168,200],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100642676","shear-wave-elastography-of-peripheral-nerves-for-early-diagnosis-of-icu-acquired-weakness-100642676",false,"NCT07594249","Shear Wave Elastography of Peripheral Nerves for Early Diagnosis of ICU-acquired Weakness","Clinical Value of Shear Wave Elastography of Peripheral Nerves for the Early Diagnosis of ICU-Acquired Weakness: A Prospective Observational Pilot Study","Inclusion Criteria:\n\n1. Age ≥ 18 years;\n2. Newly admitted to ICU with an expected ICU stay \\> 7 days;\n3. Initiated on mechanical ventilation within 24 hours of admission, with an expected ventilation duration \\> 48 hours;\n4. Patient or legally authorized representative provides written informed consent.\n\nExclusion Criteria:\n\n1. Known pre-existing neuromuscular diseases (e.g., myasthenia gravis, Guillain-Barré syndrome, amyotrophic lateral sclerosis);\n2. Pre-existing limb dysfunction that would interfere with muscle strength assessment (e.g., hemiplegia, paraplegia, severe arthritis);\n3. Presence of acute trauma, surgery, skin breakdown, infection, or severe edema at the measurement sites (wrist, elbow, ankle) that would interfere with ultrasound probe placement;\n4. Pregnant or lactating women;\n5. Any other condition that the investigator believes would make the patient unsuitable for the study.","ALL","18 Years","85 Years",{"count":20,"type":21},98,"ESTIMATED","28 Days","OBSERVATIONAL","This study aims to determine whether shear wave elastography (SWE), a non-invasive ultrasound technique that measures nerve stiffness, can help detect ICU-acquired weakness (ICU-AW) early in critically ill patients. Adults receiving mechanical ventilation in the ICU will undergo ultrasound examinations of the median and tibial nerves on Days 1, 4, and 7. The study will evaluate whether early changes in nerve elasticity can predict ICU-AW, which is usually diagnosed later using a muscle strength score that requires patient cooperation.",[26,27,28],"ICU-acquired Weakness","Critical Illness Polyneuropathy","Critical Illness Myopathy",[30,31,32,33,34],"Shear Wave Elastography","Peripheral Nerve","Ultrasonography","Critical Care","Early Diagnosis","NOT_YET_RECRUITING","2026-06-13",{"date":38,"type":39},"2026-06-16","ACTUAL",{"date":41,"type":21},"2026-07-01",{"date":43,"type":21},"2027-06-30",{"name":45,"class":46},"First Affiliated Hospital of Wannan Medical College","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":63,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":79},"100594290","nlrp3-inflammasome-and-physical-therapy-in-icu-acquired-weakness-100594290","NCT07017517","NLRP3 Inflammasome and Physical Therapy in ICU-Acquired Weakness","Effect of Physical Therapy on NLRP3 Inflammasome Activation and Muscle Atrophy in Critical Illness Myopathy (PT-NLRP3-CIM).","PT-NLRP3-CIM","Inclusion Criteria:\n\n* Medical diagnosis of sepsis upon ICU admission.\n* Receiving invasive mechanical ventilation with a projected requirement ≥7 days.\n* SOFA score ≥8 for three consecutive days within the first five days of ICU admission.\n\nExclusion Criteria:\n\n* Neurocritical illness.\n* Prior malnutrition or cachexia.\n* Pre-existing neuromuscular disease.\n* Coagulopathy (severe liver disease or continuous dialysis).\n* Thrombocytopenia \\\u003C20,000 platelets\u002FμL.\n* Prior Clinical Frailty Scale ≥4.\n* Lower limb amputation or fractures.\n* Ongoing chemotherapy.\n* Pregnancy.\n* BMI \\>35.\n* Uncontrolled epilepsy.\n* Allergy to ultrasound gel.\n* Prior prolonged corticosteroid therapy.\n* Expected ICU stay \\\u003C7 days.\n* Imminent death.\n* Legal guardian refusal to provide informed consent.",{"count":57,"type":21},24,"INTERVENTIONAL",[60],"NA","The goal of this clinical trial is to study whether physical therapy can reduce NLRP3 inflammasome activation and muscle atrophy in patients with critical illness myopathy (CIM). It will also explore the role of NLRP3 inflammasome in the pathophysiology of CIM.\n\nThe main questions this study aims to answer are:\n\nIs NLRP3 inflammasome activation associated with muscle atrophy through the upregulation of atrogenes?\n\nDoes physical therapy attenuate NLRP3 inflammasome activation in skeletal muscle, thereby contributing to the prevention or reduction of muscle atrophy in CIM?\n\nResearchers will compare enhanced physical therapy using servo-assisted bed cycling (Motomed Letto®) in critically ill patients at risk of developing CIM during the early phase of ICU stay to conventional physical therapy (standard physiotherapy), to assess whether physical therapy reduces NLRP3 inflammasome activation and muscle degradation.\n\nParticipants will:\n\nBe randomized to receive either conventional physical therapy or enhanced physical therapy (Motomed Letto®) for 7 consecutive days. A control group of patients without CIM will also be included.\n\nUndergo assessments of NLRP3 activity, muscle atrophy markers, and transcriptomic profiles from serum and vastus lateralis muscle biopsies.\n\nBe clinically evaluated using the SOFA scale and muscle ultrasound for CIM diagnosis.\n\nBe followed up for changes in muscle strength and physical functionality.\n\nProvide sociodemographic and clinical information to be recorded throughout the study.",[28],[64,65,66,67,68],"Critical illness myopathy","Physical therapy","NALP3 inflammasome","Muscle atrophy","ICU-acquired weakness","RECRUITING","2026-05-04",{"date":72,"type":39},"2026-05-06",{"date":74,"type":39},"2026-04-20",{"date":76,"type":21},"2027-05",{"name":78,"class":46},"University of Chile",3,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":88,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":90,"conditions":91,"keywords":93,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":47},"100629722","critical-illness-weakness-outside-the-intensive-care-unit-100629722","NCT07478367","Critical Illness Weakness Outside the Intensive Care Unit.","Critical Illness Weakness Outside the Intensive Care Unit. A Prospective Cohort Study.","CRI-WEAK-OUT","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Hospitalization for acute illness in a non-ICU unit\n* For the critical illness cohort: presence of organ failure defined as a SOFA score ≥ 2 at admission or an increase (ΔSOFA) ≥ 2 during hospitalization\n* For the control cohort: SOFA score \\\u003C 2 throughout hospitalization\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* History of peripheral neuropathy, myopathy, or other neuromuscular disorders (e.g., myasthenia gravis)\n* Conditions affecting the lower limbs that prevent electrophysiological testing\n* Delirium with agitation preventing clinical evaluation\n* Coma or inability to assess muscle strength",{"count":89,"type":21},300,"When people become seriously ill, their bodies can be affected in many ways beyond the original disease. One well-known complication in patients treated in intensive care units (ICUs) is the development of severe muscle weakness caused by damage to muscles and nerves. This condition is called critical illness-related weakness and includes disorders of the nerves (neuropathy), the muscles (myopathy), or both. These problems can make it difficult for patients to move, walk, or even breathe independently, and recovery can take months or longer.\n\nSo far, most research on this type of weakness has focused on patients who were treated in ICUs. However, many hospitalized patients outside the ICU-such as those admitted to internal medicine wards or semi-intensive care units-can also experience severe infections, organ failure, inflammation, prolonged bed rest, and metabolic stress. These are the same risk factors known to cause nerve and muscle damage in ICU patients. Despite this, weakness occurring outside the ICU is often overlooked, attributed simply to \"deconditioning\" or prolonged bed rest, and not properly investigated.\n\nThe CRI-WEAK-OUT study aims to better understand whether critical illness-related weakness also occurs in hospitalized patients who are not admitted to the ICU, how often it happens, how severe it is, and what factors increase the risk of developing it.\n\nThis is a prospective observational study, meaning that patients will be followed over time during and after their hospital stay, without changing their usual medical care. The study will include about 600 adult patients hospitalized for acute illnesses in non-ICU wards across several Italian hospitals. Half of the participants will have signs of organ failure during hospitalization, while the other half will serve as a comparison group without organ failure.\n\nAll participants will undergo careful clinical evaluations shortly after hospital admission and again before discharge. Doctors will assess muscle strength, level of disability, independence in daily activities, and overall frailty using standardized and widely accepted scales. Six months after discharge, patients will be contacted by phone to evaluate their recovery and quality of life.\n\nIf a patient develops new or worsening muscle weakness during hospitalization, more detailed tests will be performed. These include electrical tests of nerves and muscles to understand whether the weakness is caused mainly by nerve damage, muscle damage, or both. In a subgroup of patients, additional blood samples will be collected to measure substances linked to inflammation and nerve injury. These biological markers may help doctors recognize the condition earlier and predict recovery.\n\nBy collecting detailed clinical, electrical, and biological information, the study aims to answer several important questions:\n\n* How common is critical illness-related weakness outside the ICU?\n* Which patients are most at risk?\n* How does this condition affect recovery and long-term independence?\n* Can blood markers help identify patients with nerve or muscle damage? The results of the CRI-WEAK-OUT study may improve awareness of this under-recognized condition, promote earlier diagnosis, and help clinicians plan better prevention and rehabilitation strategies. Ultimately, this research could lead to improved care, faster recovery, and better quality of life for many hospitalized patients who currently experience unexplained weakness after acute illness.",[92,27,28],"Critical Illness Polyneuromyopathy",[94,95,96,97,98,99,100],"critical illness neuropathy","critical illness myopathy","critical illness weakness","Non-ICU hospitalized patients","polyneuropathy","myopathy","Organ failure","2026-03-13",{"date":103,"type":39},"2026-03-17",{"date":105,"type":39},"2025-11-18",{"date":107,"type":21},"2028-11-30",{"name":109,"class":46},"Istituto Clinico Humanitas",{"id":111,"slug":112,"hasResults":11,"nctId":113,"briefTitle":114,"officialTitle":115,"acronym":116,"eligibilityCriteria":117,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":118,"enrollmentInfo":119,"targetDuration":4,"studyType":58,"phases":121,"briefSummary":122,"conditions":123,"keywords":126,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":133,"completionDateStruct":135,"leadSponsor":137,"locationsCount":139},"100579279","high-tech-rehabilitation-pathway-for-acute-adult-neuromuscular-diseases---fit4medrob-acute-mnd-project-100579279","NCT06822231","High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project","Clinical Protocol for a Pragmatic Trial on a High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases (Fit4MedRob-Acute MND Project)","Fit4MR-AcMND","Inclusion Criteria:\n\n* Adults with ages ranging from 18 to 80 years.\n* Patients with a confirmed diagnosis of acute\u002Fsubacute neuromuscular diseases (e.g. GBS, CIM, CIP)\n* Time of onset ranging from 15 to 30 days\n* Patients with lower limb strength (Medical Research Council or MRC) \\>=2 in at least two of the flexor and extensor muscles of the following joints: hip, knee and ankle\n* Possibility of obtaining informed consent\n\nExclusion Criteria:\n\n* Patients with unstable medical conditions (e.g. severe cardiovascular diseases, such as \"New York Heart Association\" - NYHA=4, respiratory distress not compensated by ventilation) that could interfere, in the clinician's judgment, with their ability to safely participate in the study or to perform the assessments related to the protocol.\n* Patients currently participating in other clinical trials that could interfere with this study.\n* Pregnant or breastfeeding women.","80 Years",{"count":120,"type":21},124,[60],"The goal of this study is determine if a high-tech rehabilitation circuit is more effective than usual rehabilitation methods in improving functional outcome, particularly balance control, for patients with acute neuromuscolar diseases. The main question it aims to answer is:\n\nAre high-tech rehabilitation interventions, including robotic systems, virtual reality, and stabilometric platforms, more effective than traditional rehabilitation methods in improving balance, motor function, fatigue levels, sarcopenia, cognitive engagement, and overall quality of life in patients with acute neuromuscular diseases (NMDs)? Researchers will compare a robotic treatment group, that consists in an high-tech rehabilitation, with a control group, that will receive the traditional rehabilitative treatment.",[28,124,125],"Guillain Barré Syndrome","Critical Illness Polyneuromyopathy (CIPNM)",[127,128,129],"high-tech rehabilitation","acute neuromuscular diseases","robotic platform","2026-03-02",{"date":132,"type":39},"2026-03-03",{"date":134,"type":39},"2025-05-28",{"date":136,"type":21},"2026-11",{"name":138,"class":46},"Istituti Clinici Scientifici Maugeri SpA",8,{"id":141,"slug":142,"hasResults":11,"nctId":143,"briefTitle":144,"officialTitle":145,"acronym":146,"eligibilityCriteria":147,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":148,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":150,"conditions":151,"keywords":156,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":160,"lastUpdatePostDateStruct":161,"startDateStruct":162,"completionDateStruct":164,"leadSponsor":166,"locationsCount":79},"100347976","metabolomics-study-on-postoperative-intensive-care-acquired-muscle-weakness-100347976","NCT03810768","Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness","Metabolomics Pilot Study on Postoperative Intensive Care Acquired Muscle Weakness (MIRACLE-I Study)","MIRACLE I","Inclusion Criteria:\n\n* invasive mechanically ventilated critically ill patient with expected intensive care unit stay \\> 3 days\n* postoperative patient\n* ≥ 18 years old\n* American Society of Anesthesiology (ASA) classification ≥ III\n\nExclusion Criteria:\n\n* moribund patient\n* non-curative care (comfort care)",{"count":149,"type":21},20,"In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing.\n\nAim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.",[152,33,153,28,27,154,155],"Metabolomics","Critical Illness","Intensive Care (ICU) Myopathy","Muscle Weakness",[157,158,159],"pilot trial","muscle biopsy","blood metabolome","2026-02-28",{"date":132,"type":39},{"date":163,"type":39},"2022-09-02",{"date":165,"type":21},"2026-12-31",{"name":167,"class":46},"Technical University of Munich",{"id":169,"slug":170,"hasResults":11,"nctId":171,"briefTitle":172,"officialTitle":173,"acronym":174,"eligibilityCriteria":175,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":176,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":178,"conditions":179,"keywords":185,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":191,"lastUpdatePostDateStruct":192,"startDateStruct":194,"completionDateStruct":196,"leadSponsor":198,"locationsCount":47},"100343574","recovery-from-icuaw-following-severe-respiratory-and-cardiac-failure-100343574","NCT03753412","Recovery From ICUAW Following Severe Respiratory and Cardiac Failure","Prospective Observational Study Regarding the Determinants of Functional Disability and Quality of Life in Patients Recovering From Severe Acute Cardiac or Respiratory Failure Considered for Mechanical Cardiorespiratory Support (CLEVERER)","CLEVERER","Inclusion Criteria:\n\n* Above the age of 18\n* Adults with severe cardio-respiratory failure requiring ECMO.\n* Adults who have had personal and professional consultees agree to enrol them in the trial.\n\nExclusion criteria:\n\n* Previous Stroke\n* Neuromuscular disease\n* Malignancy\n* Underlying neuromuscular disease\n* paediatrics",{"count":177,"type":21},100,"To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.",[180,181,154,182,183,184,28],"Intensive Care Unit Syndrome","Intensive Care Neuropathy","Acute Respiratory Distress Syndrome","Cardiac Failure","Respiratory Failure",[186,187,188,189,190],"Extra Corporeal Membrane Oxygenation (ECMO)","Intensive Care Unit Acquired Weakness (ICUAW)","Critical Illness Polyneuromyopathy (CIPM)","Ultrasound (US)","Health Related Quality of Life (HRQoL)","2026-01-05",{"date":193,"type":39},"2026-01-07",{"date":195,"type":39},"2019-04-09",{"date":197,"type":21},"2026-09-26",{"name":199,"class":46},"Barts & The London NHS Trust",{"id":201,"slug":202,"hasResults":11,"nctId":203,"briefTitle":204,"officialTitle":205,"acronym":206,"eligibilityCriteria":207,"healthyVolunteers":208,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":209,"targetDuration":4,"studyType":58,"phases":211,"briefSummary":212,"conditions":213,"keywords":214,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":218,"lastUpdatePostDateStruct":219,"startDateStruct":221,"completionDateStruct":223,"leadSponsor":225,"locationsCount":47},"100576522","improved-recovery-of-walking-in-acquired-muscle-weakness-100576522","NCT06786390","Improved Recovery of Walking in Acquired Muscle Weakness","Regaining Walking Ability Easier and Better in Critical Illness Polyneuropathy and Myopathy","Re-Walk-Easy","Critical Illness Patient Inclusion Criteria:\n\n* clinical diagnosis of tetra\u002Fparaparesis of peripheral origin as disclosed by ENG\u002FEMG examination;\n* be independent before the episode of critical illness\n\nCritical Illness Patient Exclusion Criteria:\n\n* history of previous comorbidity for ICU-AW;\n* previous known chronic polyneuropathy;\n* severe coagulopathy;\n* severe disorder of consciousness;\n* contraindications to Electrical Stimulation application\n\nHealthy Subjects Exclusion Criteria:\n\n* Prosthetic implants\n* musculoskeletal, neurological, cardiovascular and pulmonary disorders that may alter the gait",true,{"count":210,"type":21},72,[60],"The aim of Re-Walk-Easy is to evaluate the effects of rehabilitation based on electrical stimulation on the motor performance of critically ill patients. The study will also investigate the pathophysiology of the two forms-the myopathic-predominant and the polyneuropathic-predominant variants-by examining the longitudinal progression of CIP and CIM and determining which form benefits more from electrical stimulation as a rehabilitative approach.",[28,27],[215,216,217],"Functional Electrical Stimulation","Acquired Muscle Weakness","Rehabilitation","2025-02-27",{"date":220,"type":39},"2025-03-03",{"date":222,"type":39},"2025-02-25",{"date":224,"type":21},"2027-12",{"name":226,"class":46},"Fondazione Don Carlo Gnocchi Onlus"]